With the recent announcement of Rite Aid store closures, now is an ideal time to reassess your 340B program strategy. These changes may impact several key areas, including:
- Patient Access: Rite Aid patients may need to transfer their prescriptions to new pharmacies, potentially affecting your covered entity’s capture rate.
- Manufacturer Designations: Shifts in pharmacy networks may require updates to manufacturer designations to maintain compliance and optimize savings.
- Third-Party Administrator (TPA) Performance: It’s important to evaluate whether your current TPA is effectively supporting your program through ongoing industry changes.
Washington Hospital Services (WHS) partners with SunRx because of their commitment to a customer service model that prioritizes the needs of covered entities. Their hands-on approach ensures that your 340B program remains compliant, efficient and financially optimized.
If you have questions about your program or are unsure whether recent industry developments require action, SunRx is ready to walk through your program with you to ensure you’re not leaving any dollars on the table. Contact Ed Phippen at Edp@wsha.org or (206) 216-2556 for more information. (Ed Phippen)